SUMMARY The effects of indomethacin on antigen induced arthritis in rabbits have been investigated. Arthritis was induced in the knee joints of sensitised rabbits by intra-articular injection of antigen. Swelling df the joints was measured for 14 days after antigen challenge, and groups of animals were killed on days 1, 7, or 14 for collection of synovial fluids and tissues. Indomethacin (1 mg/kg, three times daily) reduced joint swelling and the prostaglandin E2 concentrations in synovial fluid. In addition, indomethacin increased the loss of proteoglycan from articular cartilage and the numbers of lymphocytes in the inflamed synovial lining. These findings suggest that the symptomatic benefits of indomethacin and related drugs in inflammatory arthritis may be achieved at the expense of significant adverse effects on joint tissues.
The so called 'non-steroidal anti-inflammatory drugs', which include aspirin, phenylbutazone, and indomethacin, are widely prescribed for all forms of synovitis, whether due to mechanical irritation (osteoarthritis), crystal deposition (gout and pseudogout), or a disturbance of the immune response as is postulated in rheumatoid arthritis. This group of drugs is characterised by a common pharmacological activity-inhibition of the synthesis of prostaglandins in inflamed tissues-and this specific mechanism accounts for their analgesic, antipyretic, and anti-inflammatory properties.' In the clinic it is recognised that these drugs ease pain and diminish swelling, but there is no good evidence that they halt the progression of chronic erosive arthritis.2 3 Indeed, there has long been a suspicion that non-steroidal anti-inflammatory drugs may exacerbate some features of arthritis. For example, in primary osteoarthritis of the human hip a correlation has been reported between non-steroidal anti-inflammatory drug treatment and acetabular bone destruction.4 Furthermore, it has been shown Accepted for publication 6 Groups of rabbits were killed 1, 7, or 14 days after antigen challenge. Sterile isotonic saline (1 ml) was injected into both knee joints of each animal before the joints were opened and the resultant joint washes taken for leucocyte and rice body counts and estimations of prostaglandin E2 concentrations by specific radioimmunoassay.'0
CARTILAGE PROTEOGLYCAN MEASUREMENTS
The articular cartilage was dissected from the ends of both femurs and the proteoglycan content determined by assay of sulphated glycosaminoglycans (the heteropolysaccharide side chains of proteoglycan) after digestion with papain (Sigma) for one to two hours at 65°C. Glycosaminoglycans were measured by the 1,9-dimethylmethylene blue binding assay. ' 1 The proteoglycan content of cartilage was expressed as ,ug glycosaminoglycan/mg wet weight or dry weight of tissue.
HISTOLOGICAL ASSESSMENT OF SYNOVIAL TISSUES
The detailed method of histological assessment is described elsewhere. 12 Briefly, after removal of synovial fluid and articular cartilage the femur was excised at mid-shaft, and the distal femur with surrounding synovial tissue and patella was decalcified in buffered formic acid. Blocks (2 mm thick) were cut from decalcified specimens at right angles to the femoral shaft and passing through the upper third of the patella and the posterior articular surface of the condyles. These blocks were embedded in paraffin for conventional sectioning and staining with haematoxylin and eosin. Sections were examined with a x40 objective and a 1 cm square graticule divided into square millimetres. Lymphocytes and polymorphonuclear leucocytes were counted in 10 bands of tissue 250 Rm wide at 2 5 mm intervals along the tissue surface running from the synovial surface to deep fibrous tissue.
Results
Intra-articular injection of antigen induced an increase in joint diameter of 5-6 mm after 24 hours. Swelling declined slightly after four days but persisted at approximately 5 mm for up to 14 days (Fig. 1) . Indomethacin did not prevent the initial swelling but significantly reduced swelling between eight and 14 days by about 50% (Fig. 1) .
Synovial fluids from control animals contained up to 10 ng/ml prostaglandin E2 at 24 hours, which declined to about 3 ng/ml after 14 days. At both times indomethacin significantly reduced prostaglandin E2 concentrations (Fig. 2) . After antigen challenge there was a rapid accumulation of leucocytes in the synovial fluid and leucocyte numbers remained raised at between 5x 106 and 2x 107 cells/ml for up to 14 days. Indomethacin treatment did not significantly alter the total number of leucocytes in the fluid at any time. Microscopic examination of the synovial -fluid showed the presence of 'rice bodies', which are thought to be composed of a mixture of fibrin and detached fragments of synovial tissue. 13 14 Synovial fluids from arthritic joints from animals killed at day 7 contained 1-4 (0. 1) X 104 rice bodies/ml (mean (SEM); n=5), and rice bodies were increased (14.1 'rhe glycosaminoglycan content of articular cartilage taken from arthritic joints decreased progressively from days 1 to 14, reaching a loss of more than 40% of the proteoglycan by day 14 (Fig.  3) . At days 1, 7, and 14 indomethacin treatment caused a greater proteoglycan loss (Fig. 3) weight of cartilage, indicating that the indomethacin effect could not be explained by increased hydration of this tissue. Histological examination of the inflamed synovium from arthritic joints 14 days after antigen challenge showed a considerable thickening of the synovial membrane with an increase of approximately sevenfold in the total numbers of cells and the appearance of large numbers of lymphocytes (Fig. 4) . Indomethacin treatment did not significantly change the total numbers of cells but almost doubled the lymphocyte count (Fig. 4) (18) polymorphonuclear leucocytes/10 bands (mean (SEM); n=5), while tissue from indomethacin treated animals contained 171 (38) (n=5). Very few polymorphonuclear leucocytes were seen at days 4, 7, or 14.
Discussion
The results reported in this study confirm that indomethacin reduces joint swelling and synovial fluid prostaglandin E2 concentrations in antigen induced arthritis.'5 Probably, inhibition of prostaglandin synthesis contributes to the reduction of swelling as prostaglandin E2 enhances plasma extravasation and oedema.' We have now shown, however, that indomethacin accelerates proteoglycan loss from articular cartilage in a model of immune arthritis which closely resembles human rheumatoid disease in terms of joint histopathology. The increased numbers of rice bodies in the synovial fluid also suggest increased degenerative activity.
Possibly, the enhanced cartilage damage in response to indomethacin treatment may be due to reduction in the quantity of inflammatory exudate, which contains protease inhibitors. This is unlikely, however, as indomethacin increased proteoglycan depletion at day 1, a time when there was no reduction in joint swelling (and presumably, exudate volume).
An alternative explanation is that inhibition of the production of prostaglandin E2, which is immunosuppressive, leads to greater cytokine generation and, consequently, greater joint destruction. Prostaglandin E2 is known to suppress and indomethacin enhance the production of interleukin 1 from mononuclear cells.16 The increased concentration of interleukin 1 is likely to have deleterious effects on the integrity of the articular cartilage as interleukin 1 is a potent inducer of cartilage degradation in vivo. The' increased production of interleukin 1 may, in turn, lead to greater infiltration or proliferation of lymphocytes, or both. Alternatively, the inhibition of prostaglandin E2 synthesis may contribute directly to the increase in lymphocyte numbers as rostaglandin E2 inhibits lymphocyte proliferation. 7 Furthermore, Lewis and Barrett have shown that indomethacin dramatically enhances the proliferation of human mononuclear cells in response to mitogens.'8 An increased number of activated lymphocytes may contribute to cartilage matrix breakdown by interacting with antigen presenting cells and consequently causing the generation of more cytokines. The enhancement of cartilage proteoglycan loss seen in indomethacin treated animals occurred before major lymphocyte influx was evident, however, suggesting that other mechanisms are involved in the early stages.
The causal relations between cartilage damage and lymphocyte influx in chronic synovitis are unclear. Muirden and Mills suggested an inverse temporal relation between tissue destruction and lymphocyte infiltration.'9 Observations on human tissue usually involve assessment of cell density rather than total cell numbers, however. Tissue undergoing damage to matrix is commonly oedematous and expanded by fibrin deposits. Lymphocyte density may be reduced in such tissues, being diluted locally by acellular or necrotic material, whereas total numbers may be high. In our study the full thickness of synovium was analysed, giving a measure of total cell numbers in the joint. The fact that total cell numbers were not changed significantly by indomethacin treatment, despite the increase in lymphocyte numbers, suggests that the numbers of infiltrating monocytes or proliferating fibroblasts might have been reduced. Because lymphocytes formed a relatively small proportion of the total cells, however, the fractional reduction of other cells was small and cannot be considered significant on the present evidence.
We conclude from these studies that indomethacin, although having clear therapeutic effects in reducing the symptoms of arthritis, may actually exacerbate some of the chronic degenerative aspects of immune arthritis. These findings emphasise the need for new treatments to modulate tissue degeneration to be used as an adjunct to the current antiinflammatory and analgesic drugs. 
